Novo Nordisk's pricing approaches in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who has accused the company of price tag gouging, mentioning the stark contrast amongst U.S. rates and those in Europe and copyright.Nevertheless, It is really crucial to remain mindful that these savings mightn't apply universally, Special